XML 80 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:    
Net income (loss) $ (2,889,147) $ 1,464,969
Adjustments to reconcile net income (loss) to net cash used by operating activities:    
Depreciation and amortization 1,403,836 1,281,634
Stock based compensation 421,673 131,733
Paid in-kind interest 12,000
Change in deferred tax provision (125,419) 9,673
Amortization of deferred financing costs and debt discount 1,901 46,251
Gain on extinguishment of liabilities, net (3,532,659)
Impairment of investment 160,000
Decrease (increase) in assets:    
Accounts receivable (1,994,029) (192,593)
Inventory (144,097) 87,653
Prepaid expenses and other assets (133,844) (31,198)
Increase (decrease) in liabilities:    
Accounts payable 145,003 618,836
Accrued expenses (279,036) (113,793)
Other liabilities (1,749,715) (1,325,427)
Net cash used by operating activities (5,342,874) (1,382,921)
Cash flows from investing activities:    
Purchase of property, plant and equipment (988,876) (1,003,413)
Purchase of investment (1,829,245)
Issuance of notes receivable (793,195)
Purchase of intangible assets (369,735) (100,138)
Net cash used by investing activities (3,981,051) (1,103,551)
Cash flows from financing activities:    
Payments of long-term debt (274,468) (1,188,081)
Borrowings from lines of credit, net 587,750 502,155
Borrowings from revolving lines of credit, net 500,000
Borrowings from conversion of note 500,000
Issuances of common stock, net of issuance costs 6,658,906 887,755
Receipt of subscription receivable, net of issuance costs 288,000
Net cash provided by financing activities 7,972,188 489,829
Net decrease in cash (1,351,737) (1,996,643)
Cash and cash equivalents at beginning of year 2,447,985 4,444,628
Cash and cash equivalents at end of year $ 1,096,248 $ 2,447,985